EUVIMEDEUVIMED entdecken
Crossref

Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer

Tae Hee Hong, Soohyun Hwang, Chris Abbosh, Abhijit Dasgupta, Yeong Jeong Jeon, Junghee Lee, Seong Yong Park, Jong Ho Cho, Yong Soo Choi, Young Mog Shim, Tiffany Hung, Jörg Bredno und 3 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Tae Hee Hong und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea; Department…. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: AstraZeneca PLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNACarcinoma, Non-Small-Cell LungLung NeoplasmsNeoplasm Recurrence, LocalPneumonectomyBiomarkers, TumorHumansFemaleMiddle AgedAgedMaleNeoplasm StagingProspective StudiesRisk Factors

Stichwörter der Autor:innen

CtDNAEarly-stageNSCLCPrognosisSublobar resection

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic and Cardiovascular Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea; Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei Un…
  • Department of Pathology and Translational Genomics, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea; Lunit Inc., Seoul, South Korea.
  • Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Early Data Science, Oncology Data Science R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Department of Thoracic and Cardiovascular Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea.
  • Department of Thoracic and Cardiovascular Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, Sou…

Förderung

  • AstraZeneca PLC

Zitieren

APA

Hong, T. H., Hwang, S., Abbosh, C., Dasgupta, A., Jeon, Y. J., Lee, J., Park, S. Y., Cho, J. H., Choi, Y. S., Shim, Y. M., Hung, T., Bredno, J., Hodgson, D., Ahn, M. J., & Kim, H. K. (2025). Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115237

Vancouver

Hong TH, Hwang S, Abbosh C, Dasgupta A, Jeon YJ, Lee J, et al. Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115237

BibTeX
@article{Hong2025,
  author = {Hong, Tae Hee and Hwang, Soohyun and Abbosh, Chris and Dasgupta, Abhijit and Jeon, Yeong Jeong and Lee, Junghee and Park, Seong Yong and Cho, Jong Ho and Choi, Yong Soo and Shim, Young Mog and Hung, Tiffany and Bredno, Jörg and Hodgson, Darren and Ahn, Myung-Ju and Kim, Hong Kwan},
  title = {Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115237}
}
Kostenlos starten →